Alessandro Pinto has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Subepithelial Connective Tissue Graft Versus De-Epithelialized Free Gingival Graft with the Modified Coronally Advanced Tunnel Technique: A Split-Mouth Pilot Randomized Trial

    by Simran Jaisinghani, Nihal Devkar, Paolo Carosi, Rucha Jadhav, Bhagyashree Jabade, Ankita Dhamapurkar, Prerna Ladda, Alessandro Pinto, Claudia Lorenzi

    This single-center, split-mouth, single-blind pilot randomized trial compared patient morbidity, healing and root coverage between the subepithelial connective tissue graft (SCTG) and the de-epithelialized free gingival graft (D-FGG) when combined with the modified coronally advanced tunnel (MCAT) technique in multiple adjacent gingival recessions. Sixteen systemically healthy patients with bilateral Miller Class I/II (Cairo RT1) recessions were enrolled, and contralateral sides were randomly allocated to MCAT + SCTG (control) or MCAT + D-FGG (test) by means of sequentially numbered, opaque, sealed envelopes (SNOSE). Patient-reported outcomes (pain, chewing discomfort, bleeding) and the Landry Healing Index were assessed at 1 and 2 weeks; recession depth, mean root coverage (mRC) and Root Coverage Esthetic Score (RES) were evaluated at 6 months. Both techniques achieved high mRC (test: 94.22% ± 10.28%; control: 94.60% ± 9.99%) and RES (test: 8.02 ± 0.63; control: 8.14 ± 0.77), with no statistically significant intergroup differences. Donor-site pain was significantly lower in the D-FGG group, whereas early chewing discomfort and bleeding were higher. Because the trial was not powered for equivalence or non-inferiority, these preliminary findings are hypothesis-generating and require confirmation in adequately powered trials.

  • Open Access

    Cortical Laminar Bone Membrane in Implant Dentistry: Biological Basis, Clinical Protocols, and Outcomes

    by Alessandro Pinto, Vincenzo Mazzetti, Paolo Carosi, Claudia Lorenzi

    Cortical laminar bone membranes (CLBMs) combine mechanical strength with controlled resorption to overcome the limitations of conventional guided bone regeneration membranes. This narrative review synthesizes the clinical efficacy and comparative outcomes of CLBMs from human studies. A systematic literature search identified 13 human clinical studies evaluating CLBMs from xenogeneic (porcine, equine, bovine) and autogenous sources. Compared to conventional alternatives, CLBMs demonstrated superior outcomes: horizontal ridge augmentation achieved 3.1–5.8 mm gains with CLBMs versus 2.0–3.0 mm with collagen membranes (50–100% improvement); membrane exposure rates were 3–8% (CLBMs) versus 15–30% (titanium mesh); and socket preservation achieved a 72% resorption reduction versus natural healing controls. Vertical augmentation achieved 7–11 mm gains. Maxillary sinus augmentation achieved a 100% implant success (1–5 year follow-up). The overall implant survival rates ranged 90.9–100% with CLBMs, exceeding the reported success rates (85–95%) of conventional GBR approaches, with complication rates of 0–12.5%. A histomorphometric analysis demonstrated new bone formation of 29.7–40% at 6 months, with a residual biomaterial of 26.2–35%. CLBMs demonstrate favorable exposure rates and excellent biocompatibility. These membranes support lateral, vertical, and combined defect reconstruction, with reduced donor-site morbidity compared to autogenous approaches. High-quality comparative trials and extended follow-up studies are needed to establish definitive clinical guidelines.